Literature DB >> 21866108

The effect of treatment on monocyte and lymphocyte cytokine release in patients with aldosteronoma.

Robert Krysiak, Boguslaw Okopien.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21866108     DOI: 10.1038/hr.2011.142

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  5 in total

1.  New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects.

Authors:  Ana Paula Davel; Iris Z Jaffe; Rita C Tostes; Frederic Jaisser; Eric J Belin de Chantemèle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-29       Impact factor: 4.733

2.  Divergent Characteristics of T-Cell Receptor Repertoire Between Essential Hypertension and Aldosterone-Producing Adenoma.

Authors:  Che-Mai Chang; Kang-Yung Peng; Chieh-Kai Chan; Yu-Feng Lin; Hung-Wei Liao; Jan-Gowth Chang; Mai-Szu Wu; Vin-Cent Wu; Wei-Chiao Chang
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

3.  Risk of sepsis in patients with primary aldosteronism.

Authors:  Chieh-Kai Chan; Ya-Hui Hu; Likwang Chen; Chin-Chen Chang; Yu-Feng Lin; Tai-Shuan Lai; Kuo-How Huang; Yen-Hung Lin; Vin-Cent Wu; Kwan-Dun Wu
Journal:  Crit Care       Date:  2018-11-21       Impact factor: 9.097

4.  Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism.

Authors:  Charlotte D C C van der Heijden; Esther M M Smeets; Erik H J G Aarntzen; Marlies P Noz; Houshang Monajemi; Simone Kersten; Charlotte Kaffa; Alexander Hoischen; Jaap Deinum; Leo A B Joosten; Mihai G Netea; Niels P Riksen
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

Review 5.  Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone.

Authors:  N Muñoz-Durango; A Vecchiola; L M Gonzalez-Gomez; F Simon; C A Riedel; C E Fardella; A M Kalergis
Journal:  Biomed Res Int       Date:  2015-09-10       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.